Expressions and Clinical Significances of Angiopoietin-1, Angiopoietin-2, and Tie-2 Receptor in Patients With Colorectal Cancer

다국어 초록 (Multilingual Abstract)

Purpose: Angiopoietin-1 (Ang-1) plays a crucial role in vascular and hematopoietic development, mainly through its cognate receptor, Tie-2. Increased levels of Ang-2 have been shown to be correlated with abnormal tumor angiogenesis in several malignancies. Hence, we estimated the increased expression of Ang-2 relative to Ang-1 in patients with colorectal cancer and correlated our finding with prognosis in order to investigate the relationships between the expressions of Ang-1/Ang-2/Tie-2 receptor and the clinical parameters or overall survival of such patients.
Methods: We retrospectively analyzed 114 tissue samples from patients with colorectal cancer by using immunohistochemistry (IHC) to examine Ang-1, Ang-2, and Tie-2 expressions and to investigate the relationship between those expressions and clinical parameters or overall survival of such patients. A Western blot analysis was used for Ang-2 expression.
Results: IHC staining showed a link between Ang-1 and Tie-2 (P = 0.018), as well as meaningful correlations between Ang-2 and Tie-2 receptor (P = 0.022) and between lymph-node metastasis and Ang-2 (P = 0.025). The stronger the IHC staining for Ang-2 expression was, the shorter the cumulative survival was (P = 0.016).
Conclusion: A relationship was found to exist between Ang-2 and Tie-2 expressions. The Ang-2 was correlated with lymph-node metastasis, and high expression of Ang-2 was indicative of poor overall survival. These findings suggest that Ang-2 is a useful prognostic marker in the management of patients with colorectal cancer. In addition, we suggest that Ang/Tie-2 signaling plays an important role in the progression of colorectal cancer.

참고문헌 (Reference)

1 Ferrara N, "VEGF and the quest for tumour angiogenesis factors" 2 : 795-803, 2002

2 Saharinen P, "VEGF and angiopoietin signaling in tumor angiogenesis and metastasis" 17 : 347-362, 2011

3 Eklund L, "Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling" 312 : 630-641, 2006

4 Ahmad SA, "The effects of angiopoietin-1 and -2 on tumor growth and angiogenesis in human colon cancer" 61 : 1255-1259, 2001

5 Huang H, "Targeting the ANGPTTIE2pathway in malignancy" 10 : 575-585, 2010

6 Petrillo M, "Novel targets for VEGF-independent anti-angiogenic drugs" 21 : 451-472, 2012

7 Jass SR, "Histological typing of intestinal tumors. 2nd ed. World Health Organization. International Histological Classification of Tumours" Springer-Verlg 1989

8 Hanahan D, "Hallmarks of cancer: the next generation" 144 : 646-674, 2011

9 Holopainen T, "Effects of angiopoietin-2-blocking antibody on endothelial cell-cell junctions and lung metastasis" 104 : 461-475, 2012

10 Casanovas O, "Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in latestage pancreatic islet tumors" 8 : 299-309, 2005

11 Sato TN, "Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation" 376 : 70-74, 1995

12 Lemieux C, "Angiopoietins can directly activate endothelial cells and neutrophils to promote proinflammatory responses" 105 : 1523-1530, 2005

13 Albini A, "Angiopoietin2 and tie2: tied to lymphangiogenesis and lung metastasis. New perspectives in antimetastatic antiangiogenic therapy" 104 : 429-431, 2012

14 Maisonpierre PC, "Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis" 277 : 55-60, 1997

15 Kim I, "Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3’-Kinase/Akt signal transduction pathway" 86 : 24-29, 2000

16 Carmeliet P, "Angiogenesis in cancer and other diseases" 407 : 249-257, 2000